We are taking deliberate steps to strengthen our pharmaceutical ecosystem. This includes enhancing the capacity of our National Regulatory Authority to achieve World Health Organisation Maturity Level 3, thereby reinforcing global confidence in the quality, safety, and efficacy of Kenyan manufactured products.
Our goal is to position Kenya as a regional hub for pharmaceutical manufacturing, health innovation, and medical supply chains, serving both the Kenyan and the wider African markets.
This ambition is reinforced by our strategic position as the gateway to Eastern Africa’s fast-growing economic bloc, supported by a strong and expanding domestic market, world-class logistics, and a dynamic investment environment.
Addressed the Africa Initiative for Medical Access and Manufacturing (AIM2030) meeting ahead of the opening of the Africa Forward Summit, Nairobi.
Called on African governments to fully implement commitments on regulatory harmonisation, market integration and industrial policy in order to unlock Africa's manufacturing potential.